YAP1 inhibition radiosensitizes triple negative breast cancer cells by targeting the DNA damage response and cell survival pathways-Reference-Cited by-同舟云学术

YAP1 inhibition radiosensitizes triple negative breast cancer cells by targeting the DNA damage response and cell survival pathways

Published:2017-10-20 Issue:58 Volume:8 Page:98495-98508
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Andrade Daniel¹,Mehta Meghna¹,Griffith James¹,Panneerselvam Janani²,Srivastava Akhil²,Kim Tae-Dong³,Janknecht Ralf³⁴,Herman Terence¹⁴,Ramesh Rajagopal²⁴,Munshi Anupama¹⁴

Affiliation:

1. Department of Radiation Oncology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104, USA

2. Department of Pathology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104, USA

3. Department of Cell Biology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104, USA

4. Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the Hippo pathway to prevent radioresistance brain metastases from the lung (Review);International Journal of Oncology;2024-05-17

2. Nuclear phosphoinositide signaling promotes YAP/TAZ-TEAD transcriptional activity in breast cancer;The EMBO Journal;2024-04-02

3. CYR61 confers chemoresistance by upregulating survivin expression in triple-negative breast cancer;Carcinogenesis;2024-03-06

4. Differential Sensitivity to Ionizing Radiation in Gemcitabine-Resistant and Paclitaxel-Resistant Pancreatic Cancer Cells;International Journal of Radiation Oncology*Biology*Physics;2023-10

5. Modern Stereotactic Radiotherapy for Brain Metastases from Lung Cancer: Current Trends and Future Perspectives Based on Integrated Translational Approaches;Cancers;2023-09-18